Report

Global Substance Abuse Treatment Market Size study, by Abuse Type (Alcohol Dependence, Tobacco/Nicotine Addiction, Drug Abuse, Others), by End-User (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers) and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & forecasts, 2018-2027 (USD Billion)
1.2.1. Substance Abuse Treatment Market, by Region, 2018-2027 (USD Billion)
1.2.2. Substance Abuse Treatment Market, by Abuse Type, 2018-2027 (USD Billion)
1.2.3. Substance Abuse Treatment Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Substance Abuse Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Substance Abuse Treatment Market Dynamics
3.1. Substance Abuse Treatment Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Substance Abuse Treatment Market: Industry Analysis
4.1. Porter's 5 force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Substance Abuse Treatment Market, by Abuse Type
5.1. Market Snapshot
5.2. Global Substance Abuse Treatment Market by Abuse Type, Performance - Potential Analysis
5.3. Global Substance Abuse Treatment Market Estimates & forecasts by Abuse Type 2017-2027 (USD Billion)
5.4. Substance Abuse Treatment Market, Sub Segment Analysis
5.4.1. Alcohol Dependence
5.4.2. Tobacco/Nicotine Addiction
5.4.3. Drug Abuse
5.4.4. Others
Chapter 6. Global Substance Abuse Treatment Market, by End-User
6.1. Market Snapshot
6.2. Global Substance Abuse Treatment Market by End-User, Performance - Potential Analysis
6.3. Global Substance Abuse Treatment Market Estimates & forecasts by End-User 2017-2027 (USD Billion)
6.4. Substance Abuse Treatment Market, Sub Segment Analysis
6.4.1. Outpatient Treatment Centers
6.4.2. Residential Treatment Centers
6.4.3. Inpatient Treatment Centers
Chapter 7. Global Substance Abuse Treatment Market, Regional Analysis
7.1. Substance Abuse Treatment Market, Regional Market Snapshot
7.2. North America Substance Abuse Treatment Market
7.2.1. U.S. Substance Abuse Treatment Market
7.2.1.1. Abuse Type breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Substance Abuse Treatment Market
7.3. Europe Substance Abuse Treatment Market Snapshot
7.3.1. U.K. Substance Abuse Treatment Market
7.3.2. Germany Substance Abuse Treatment Market
7.3.3. France Substance Abuse Treatment Market
7.3.4. Spain Substance Abuse Treatment Market
7.3.5. Italy Substance Abuse Treatment Market
7.3.6. Rest of Europe Substance Abuse Treatment Market
7.4. Asia-Pacific Substance Abuse Treatment Market Snapshot
7.4.1. China Substance Abuse Treatment Market
7.4.2. India Substance Abuse Treatment Market
7.4.3. Japan Substance Abuse Treatment Market
7.4.4. Australia Substance Abuse Treatment Market
7.4.5. South Korea Substance Abuse Treatment Market
7.4.6. Rest of Asia Pacific Substance Abuse Treatment Market
7.5. Latin America Substance Abuse Treatment Market Snapshot
7.5.1. Brazil Substance Abuse Treatment Market
7.5.2. Mexico Substance Abuse Treatment Market
7.6. Rest of The World Substance Abuse Treatment Market

Chapter 8. Competitive intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Alkermes plc
8.2.1.1. Key information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Allergan, Inc.
8.2.3. GlaxoSmithKline plc
8.2.4. Mylan N.V.
8.2.5. Pfizer Inc.
8.2.6. Purdue Pharma L.P.
8.2.7. Reckitt Benckiser Pharmaceuticals
8.2.8. Teva Pharmaceutical Industries Ltd.
8.2.9. Forest Laboratories Ltd.
8.2.10. Accord Healthcare Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption